NATION
- Share via
Invitron Corp. of St. Louis named Charles V. Benton to the post of chief executive, replacing Moshe Alafi, who continues as the firm’s chairman. Also, William R. Srigley was named chief operating officer. Invitron develops and manufactures cell culture-derived biopharmaceutical proteins.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
